OSU Medical Center/Arthur G. James Cancer Hospital StudyCoordinator:CHCD122A2101 is a clinical research site located in Columbus, Ohio, United States 43210.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
OSU Medical Center/Arthur G. James Cancer Hospital StudyCoordinator:CHCD122A2101 has participated in 1 clinical trials.
Therapeutic areas: Chronic Lymphocytic Leukemia.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
OSU Medical Center/Arthur G. James Cancer Hospital StudyCoordinator:CHCD122A2101 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
OSU Medical Center/Arthur G. James Cancer Hospital StudyCoordinator:CHCD122A2101 has 1 clinical trials on record. Their work covers Chronic Lymphocytic Leukemia.
OSU Medical Center/Arthur G. James Cancer Hospital StudyCoordinator:CHCD122A2101 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.